Your browser doesn't support javascript.
loading
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation.
Burslem, George M; Schultz, Anna Reister; Bondeson, Daniel P; Eide, Christopher A; Savage Stevens, Samantha L; Druker, Brian J; Crews, Craig M.
Afiliação
  • Burslem GM; Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut.
  • Schultz AR; Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon.
  • Bondeson DP; Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, Connecticut.
  • Eide CA; Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon.
  • Savage Stevens SL; Howard Hughes Medical Institute, Portland, Oregon.
  • Druker BJ; Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon.
  • Crews CM; Division of Hematology and Medical Oncology, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon.
Cancer Res ; 79(18): 4744-4753, 2019 09 15.
Article em En | MEDLINE | ID: mdl-31311809

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases / Proteólise Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases / Proteólise Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article